Literature DB >> 2975554

Sucrose versus saccharin as an added sweetener in non-insulin-dependent diabetes: short- and medium-term metabolic effects.

P L Cooper1, M L Wahlqvist, R W Simpson.   

Abstract

Seventeen non-insulin-dependent diabetic patients were randomly allocated to their usual diet supplemented daily with either 28 g sucrose or 30 g starch (isoenergetic with sucrose) and saccharin (equivalent sweetness). After 6 weeks, the supplements were reversed. No significant treatment effects were observed on fasting concentrations of blood glucose, plasma insulin or serum triglycerides, or on urinary excretion of glucose, sodium or potassium. Following a standard breakfast with either sucrose or saccharin and starch, no differences between meal responses were observed. This study demonstrates no medium-term metabolic contraindications to including a moderate amount of sucrose in the diets of patients with non-insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975554     DOI: 10.1111/j.1464-5491.1988.tb01079.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

Review 1.  Fructose-containing sugars and cardiovascular disease.

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

Review 2.  Non-nutritive Sweeteners and Glycaemic Control.

Authors:  Yoona Kim; Jennifer B Keogh; Peter M Clifton
Journal:  Curr Atheroscler Rep       Date:  2019-11-19       Impact factor: 5.113

3.  Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes.

Authors:  S Temizkan; O Deyneli; M Yasar; M Arpa; M Gunes; D Yazici; O Sirikci; G Haklar; N Imeryuz; D G Yavuz
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

Review 4.  Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review.

Authors:  Vanessa Ha; Viranda H Jayalath; Adrian I Cozma; Arash Mirrahimi; Russell J de Souza; John L Sievenpiper
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 5.  The Role of Fructose, Sucrose and High-fructose Corn Syrup in Diabetes.

Authors:  Adrian I Cozma; John L Sievenpiper
Journal:  Eur Endocrinol       Date:  2014-02-28

Review 6.  Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future research.

Authors:  Allison C Sylvetsky; Jenny E Blau; Kristina I Rother
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

Review 7.  Added sugars and risk factors for obesity, diabetes and heart disease.

Authors:  J M Rippe; T J Angelopoulos
Journal:  Int J Obes (Lond)       Date:  2016-03       Impact factor: 5.095

8.  High-dose saccharin supplementation does not induce gut microbiota changes or glucose intolerance in healthy humans and mice.

Authors:  Joan Serrano; Kathleen R Smith; Audra L Crouch; Vandana Sharma; Fanchao Yi; Veronika Vargova; Traci E LaMoia; Lydia M Dupont; Vanida Serna; Fenfen Tang; Laisa Gomes-Dias; Joshua J Blakeslee; Emmanuel Hatzakis; Scott N Peterson; Matthew Anderson; Richard E Pratley; George A Kyriazis
Journal:  Microbiome       Date:  2021-01-12       Impact factor: 14.650

9.  Saccharin Stimulates Insulin Secretion Dependent on Sweet Taste Receptor-Induced Activation of PLC Signaling Axis.

Authors:  Joan Serrano; Nishita N Meshram; Mangala M Soundarapandian; Kathleen R Smith; Carter Mason; Ian S Brown; Björn Tyrberg; George A Kyriazis
Journal:  Biomedicines       Date:  2022-01-06

10.  Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association.

Authors:  Christopher Gardner; Judith Wylie-Rosett; Samuel S Gidding; Lyn M Steffen; Rachel K Johnson; Diane Reader; Alice H Lichtenstein
Journal:  Diabetes Care       Date:  2012-07-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.